Search by Drug Name or NDC
NDC 50090-1493-00 Typhim Vi 25 ug/.5mL Details
Typhim Vi 25 ug/.5mL
Typhim Vi is a INTRAMUSCULAR INJECTION, SOLUTION in the VACCINE category. It is labeled and distributed by A-S Medication Solutions. The primary component is SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN.
MedlinePlus Drug Summary
What is typhoid? Typhoid (typhoid fever) is a serious disease. It is caused by bacteria called Salmonella Typhi. Typhoid causes a high fever, fatigue, weakness, stomach pains, headache, loss of appetite, and sometimes a rash. If it is not treated, it can kill up to 30% of people who get it. Some people who get typhoid become ''carriers,'' who can spread the disease to others. Generally, people get typhoid from contaminated food or water. Typhoid is rare in the U.S., and most U.S. citizens who get the disease get it while traveling. Typhoid strikes about 21 million people a year around the world and kills about 200,000.
Related Packages: 50090-1493-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Typhoid Vaccine
Product Information
| NDC | 50090-1493 |
|---|---|
| Product ID | 50090-1493_d2373083-4379-4141-8d01-d491ed232cc7 |
| Associated GPIs | 1720008010E512 |
| GCN Sequence Number | 022678 |
| GCN Sequence Number Description | typhoid VI polysacch vaccine SYRINGE 25MCG/0.5 INTRAMUSC |
| HIC3 | W7M |
| HIC3 Description | GRAM (-) BACILLI (NON-ENTERIC) VACCINES |
| GCN | 48422 |
| HICL Sequence Number | 009656 |
| HICL Sequence Number Description | TYPHOID VACCINE VI CAPSULAR POLYSACCHARIDE |
| Brand/Generic | Generic |
| Proprietary Name | Typhim Vi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Inactivated Salmonella Typhi Vaccine [EPC], Polysaccharides, Bacterial [CS], Vaccines, Inactivated [CS], Vaccines, Typhoid [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103936 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-1493-00 (50090149300)
| NDC Package Code | 50090-1493-0 |
|---|---|
| Billing NDC | 50090149300 |
| Package | 1 SYRINGE in 1 POUCH (50090-1493-0) / .5 mL in 1 SYRINGE |
| Marketing Start Date | 1994-11-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |